CSIMarket
 


Cumberland Pharmaceuticals Inc.  (CPIX)
Other Ticker:  
 
 

CPIX's Revenue Growth by Quarter and Year

Cumberland Pharmaceuticals's Revenue results by quarter and year




CPIX Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 13.50 11.52 9.08
III Quarter September - 8.49 11.20 8.79
II Quarter June 11.58 10.16 8.67 7.41
I Quarter March 11.90 8.59 9.64 7.74
FY   23.48 40.74 41.03 33.02



CPIX Revenue second quarter 2019 Y/Y Growth Comment
Cumberland Pharmaceuticals Inc. achieved in the second quarter, above Company average Revenue increase of 13.98% year on year, to $ 11.58 millions.

Looking into second quarter results within Major Pharmaceutical Preparations industry 74 other companies have achieved higher Revenue growth. While Cumberland Pharmaceuticals Inc.' s Revenue growth of 13.98% ranks overall at the positon no. 1016 in the second quarter.




CPIX Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 17.19 % 26.87 % 12.94 %
III Quarter September - -24.2 % 27.42 % 11.41 %
II Quarter June 13.98 % 17.19 % 17 % -16.84 %
I Quarter March 38.53 % -10.89 % 24.55 % -10.93 %
FY   - -0.71 % 24.26 % -

Financial Statements
Cumberland Pharmaceuticals's second quarter 2019 Revenue $ 11.58 millions CPIX's Income Statement
Cumberland Pharmaceuticals's second quarter 2018 Revenue $ 10.16 millions Quarterly CPIX's Income Statement
New: More CPIX's historic Revenue Growth >>


CPIX Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 59.01 % 2.86 % 3.3 %
III Quarter September - -16.44 % 29.18 % 18.62 %
II Quarter June -2.68 % 18.28 % -10.06 % -4.26 %
I Quarter March -11.85 % -25.43 % 6.17 % -3.73 %
FY (Year on Year)   - -0.71 % 24.26 % -




Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #75
Healthcare Sector #197
Overall #1016

Revenue Y/Y Growth Statistics
High Average Low
10.83 % 2.77 % -6.52 %
(Sep 30 2017)   (Sep 30 2018)
Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #75
Healthcare Sector #197
Overall #1016
Revenue Y/Y Growth Statistics
High Average Low
10.83 % 2.77 % -6.52 %
(Sep 30 2017)   (Sep 30 2018)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Cumberland Pharmaceuticals's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
58.94 % 3.46 % -25.48 %
(Dec 31 2018)  


CPIX's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2019 Cumberland Pharmaceuticals Inc. disclosed fall in Revenue sequentially by -2.68% to $ 11.58 millions, from $ 11.90 millions released a quarter before.

Albeit seasonal influence normally elevate II. Quarter 2019 performance, this simply has not been enough to recover Cumberland Pharmaceuticals's performance, Elizabetta Gallo, Major Pharmaceutical Preparations industry veteran pointed out and wrote that average quarter on quarter Revenue growth is at 3.46% for CPIX.

Within Major Pharmaceutical Preparations industry 108 other companies have achieved higher Revenue quarter on quarter growth. While Cumberland Pharmaceuticals's Revenue growth quarter on quarter, overall rank is 2453.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #109
Healthcare Sector #350
Overall #2453
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #109
Healthcare Sector #350
Overall #2453
Revenue Q/Q Growth Statistics
High Average Low
58.94 % 3.46 % -25.48 %
(Dec 31 2018)  


CPIX's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2019 Cumberland Pharmaceuticals Inc. reported fall in Revenue sequentially by -2.68% to $ 11.58 millions, from $ 11.90 millions declared in the previous reporting period.

Even seasonal circumstance which usually elevate II. Quarter 2019 performance, that simply was not sufficient to salvage CPIX's achievement, Elizabetta Gallo, Major Pharmaceutical Preparations industry veteran said and continued that average sequential Revenue growth is at 3.46% for Cumberland Pharmaceuticals.

Within Major Pharmaceutical Preparations industry 108 other companies have achieved higher Revenue quarter on quarter growth. While Cumberland Pharmaceuticals's Revenue growth quarter on quarter, overall rank is 2453.


Cumberland Pharmaceuticals's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Revenue 12 Months Ending $ 45.47 $ 44.06 $ 40.74 $ 38.77 $ 41.47
Y / Y Revenue Growth (TTM) 9.65 % 10.21 % -0.69 % 0.48 % 14.64 %
Year on Year Revenue Growth Overall Ranking # 1286 # 1295 # 2134 # 0 # 1317
Seqeuential Revenue Change (TTM) 3.22 % 8.14 % 5.09 % -6.52 % 3.74 %
Seq. Revenue Growth (TTM) Overall Ranking # 1016 # 465 # 707 # 0 # 0




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2019 period, Cumberland Pharmaceuticals's cumulative twelve months Revenue were $ 45 millions, company would post below average annual Revenue growth of 3.74% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the Cumberland Pharmaceuticals's Revenue growth from the 11.9% growth in Mar 31 2019.

In the Healthcare sector 217 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1286, from total ranking in previous quarter at 1295.

Revenue TTM Q/Q Growth Statistics
High Average Low
10.83 %
2.77 %
-6.52 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 218
Overall # 1286

Revenue TTM Y/Y Growth Statistics
High Average Low
531.75 %
38.08 %
-15.22 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 197
S&P 500 # 1016
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2019 period, Cumberland Pharmaceuticals's cumulative twelve months Revenue were $ 45 millions, company would post below average annual Revenue growth of -15.22% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the Cumberland Pharmaceuticals's Revenue growth from the 11.9% growth in Mar 31 2019.

In the Healthcare sector 217 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1286, from total ranking in previous quarter at 1295.

Revenue TTM Q/Q Growth Statistics
High Average Low
10.83 %
2.77 %
-6.52 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 218
Overall # 1286

Revenue TTM Y/Y Growth Statistics
High Average Low
531.75 %
38.08 %
-15.22 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 197
S&P 500 # 1016




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CPIX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CPIX's Competitors
Revenue Growth for Cumberland Pharmaceuticals's Suppliers
Revenue Growth for CPIX's Customers

You may also want to know
CPIX's Annual Growth Rates CPIX's Profitability Ratios CPIX's Asset Turnover Ratio CPIX's Dividend Growth
CPIX's Roe CPIX's Valuation Ratios CPIX's Financial Strength Ratios CPIX's Dividend Payout Ratio
CPIX's Roa CPIX's Inventory Turnover Ratio CPIX's Growth Rates CPIX's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2019
Alphatec Holdings, Inc.  23.94 %$ 23.941 millions
Trovagene, Inc.  23.68 %$ 23.675 millions
Sensus Healthcare, Inc.  23.44 %$ 23.438 millions
Syros Pharmaceuticals, Inc.  23.20 %$ 23.200 millions
Conatus Pharmaceuticals Inc.  22.99 %$ 22.988 millions
Genmark Diagnostics, Inc.  22.98 %$ 22.977 millions
Vivus Inc  22.93 %$ 22.928 millions
Align Technology Inc  22.53 %$ 22.526 millions
Penumbra Inc  22.40 %$ 22.404 millions
Pacira Biosciences, Inc.  21.99 %$ 21.992 millions
General Cannabis Corp  21.74 %$ 21.742 millions
Nanostring Technologies Inc  21.38 %$ 21.385 millions
Intuitive Surgical Inc  20.85 %$ 20.851 millions
Orthopediatrics Corp  20.71 %$ 20.714 millions
Icad Inc  20.56 %$ 20.562 millions
Regeneron Pharmaceuticals, Inc.  20.25 %$ 20.253 millions
Infusystem Holdings, Inc  20.15 %$ 20.152 millions
Isoray, Inc.  20.02 %$ 20.025 millions
Amedisys Inc  19.77 %$ 19.772 millions
Genomic Health, Inc  19.37 %$ 19.370 millions
Repro Med Systems Inc  18.80 %$ 18.801 millions
Chimerix Inc  18.69 %$ 18.692 millions
Guardion Health Sciences, Inc.  18.20 %$ 18.205 millions
Htg Molecular Diagnostics, Inc  18.03 %$ 18.033 millions
Natera, Inc.  17.89 %$ 17.895 millions
Staar Surgical Co  16.99 %$ 16.986 millions
Sientra, Inc.  16.92 %$ 16.925 millions
Durect Corp  16.76 %$ 16.759 millions
Cambrex Corp  16.31 %$ 16.313 millions
Corcept Therapeutics Inc  15.96 %$ 15.960 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RCRS's Profile

Stock Price

RCRS's Financials

Business Description

Fundamentals

Charts & Quotes

RCRS's News

Suppliers

RCRS's Competitors

Customers & Markets

Economic Indicators

RCRS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071